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Abstract
Firefly luciferase is one of the few soluble proteins that is acted upon by a wide variety of general anesthetics and alcohols;
they inhibit the ATP–driven production of light. We have used time–resolved photolabeling to locate the binding sites of
alcohols during the initial light output, some 200 ms after adding ATP. The photolabel 3-azioctanol inhibited the initial light
output with an IC50 of 200 mM, close to its general anesthetic potency. Photoincorporation of [
3H]3-azioctanol into
luciferase was saturable but weak. It was enhanced 200 ms after adding ATP but was negligible minutes later. Sequencing
of tryptic digests by HPLC–MSMS revealed a similar conformation–dependence for photoincorporation of 3-azioctanol into
Glu-313, a residue that lines the bottom of a deep cleft (vestibule) whose outer end binds luciferin. An aromatic diazirine
analog of benzyl alcohol with broader side chain reactivity reported two sites. First, it photolabeled two residues in the
vestibule, Ser-286 and Ile-288, both of which are implicated with Glu-313 in the conformation change accompanying
activation. Second, it photolabeled two residues that contact luciferin, Ser-316 and Ser-349. Thus, time resolved
photolabeling supports two mechanisms of action. First, an allosteric one, in which anesthetics bind in the vestibule
displacing water molecules that are thought to be involved in light output. Second, a competitive one, in which anesthetics
bind isosterically with luciferin. This work provides structural evidence that supports the competitive and allosteric actions
previously characterized by kinetic studies.
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Introduction
It remains a challenge to understand how the function of a
protein can be affected when a low affinity drug such as a general
anesthetic binds to it. While such an understanding may come
from structures of general anesthetics bound to proteins, general
anesthetics often act selectively on transient states of receptors such
as open channels [1]. While some progress is being made with ion
channels [2], it is often unclear what conformation of a channel
has been crystallized and what relationship it bears to that channel
in a native environment. Thus, currently detailed mechanisms of
anesthetic action are more likely to emerge from studies of soluble
proteins. The choice of model is constrained because of the
structural diversity of general anesthetics [3], and the observation
that a given protein often only interacts with a narrow range of
anesthetics [4]. A suitable model is luciferase because it is inhibited
by a fairly wide range of general anesthetics and has long been a
focus of mechanistic studies. It is readily available and its activity is
easily monitored by its light output [5,6,7,8,9]. The structure of
firefly luciferase (Fig. 1A) has been determined in a number of
conformations [10,11,12]. Luciferase contains two binding pockets
in close structural proximity; one for ATP and the other for the
substrate luciferin in firefly luciferase (Fig. 1B. The enzyme
catalyzes the emission of light from its substrate by a series of
reactions using Mg-ATP and oxygen. The bioluminescence
reaction proceeds via the initial formation of an enzyme-bound
luciferyl-adenylate intermediate (modeled by 59-O-[N-(dehydrolu-
ciferyl)- sulfamoyl]adenosine (DSLA; Fig. 1B) that is oxidized with
the formation of an excited a-peroxylactone intermediate, AMP
and carbon dioxide. A photon is emitted during relaxation of the
lactone from the excited state to form oxyluciferin [11].
It has been hypothesized that anesthetics act on luciferase by
competing for the binding site of the substrate involved in light
emission. They compete with an aldehyde in bacterial luciferase
[8] and luciferin in the firefly luciferase [9]. When firefly luciferase
and luciferin are rapidly mixed with ATP, the initial output of light
is inhibited by general anesthetics. The dependence of this
inhibition on luciferin concentration appears to be competitive.
However, the limited solubility of anesthetics always makes it
impossible to perform such studies over a sufficiently wide
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29854concentration range to completely rule out the alternative
mechanism of a negative heterotrophic or allosteric action [13].
Indeed, greater complexity is hinted at in a number of studies. In a
steady state kinetics study on firefly luciferase, alkanols were found
to act allosterically whereas their fatty acid analogs acted
competitively [14,15]. More recently, the determination of a
crystal structure containing bromoform bound to the unliganded
American firefly luciferase, a conformation which has low affinity
for anesthetics [16], led to a more detailed kinetic analysis [17]. At
high luciferin concentrations, which surmount the competitive
inhibition, it was apparent that bromoform was still able to inhibit
light emission presumably by an allosteric action.
The aim of the present work was to locate the anesthetic sites of
action on firefly luciferase during the initial few hundred
milliseconds of ATP–induced light emission. To do so we have
employed diazirine derivatives of alkanols and benzyl alcohol and
time–resolved photolabeling to show that the degree of photo-
incorporation varies with the conformational state of luciferase.
The photolabeled residues are mainly clustered in or near the
luciferin pocket within a region of luciferase whose structure has
recently been shown to vary during the catalytic cycle [11,12].
Materials and Methods
Anesthetic Potency
General anesthetic potency was assessed with institutional
approval (Protocol #: 2006N000124/4. Research Animal Care,
Massachusetts General Hospital, 149 13th Street, Charlestown,
MA 02129,Tel: (617) 726-3495) in pre-limb bud Xenopus
tadpoles, 1.5–2 cm in length (Xenopus 1, Inc., Dexter, MI) as
previously described [18].
Materials
Recombinant luciferase derived from Luciola cruciata (Japanese
firefly) was purchased from Wako Chemicals USA Inc. (Rich-
mond, VA). Recombinant luciferase derived from Photinus pyralis
(North American firefly) was purchased from Sigma-Aldrich (St.
Louis, MO). Luciferin and adenosine 59-triphosphate (ATP) were
obtained from Sigma-Aldrich. 3-Azibutanol, 3-azioctanol and 7-
azioctanol were synthesized as previously described [19,20]. TFD-
benzyl alcohol ((4-(3-(trifluoromethyl)-3H-diazirin-3-yl)phenyl)-
methanol) was synthesized using Husain’s method [18]. [
3H]-3-
azioctanol was prepared from 3-azioctanol by American Radio-
chemical Company (St Louis, MO). Glycylglycine was obtained
from EMB Bioscience Inc. (La Jolla, Ca). Magnesium sulfate
(MgSO4) was obtained from J.T. Baker Inc. (Phillipsburg, NJ).
Sequencing-grade trypsin was purchased from Promega, Madison,
WI. All other reagents were obtained from Sigma-Aldrich (St.
Louis, MO).
Photolabeling of luciferase
Luciferase was photolabeled in the presence or absence of ATP
in two time domains: after a 30 min pre-incubation with all
ligands, and 200 ms after rapidly mixing the enzyme with
photolabels (time-resolved photolabeling). For equilibrium label-
ing, recombinant luciferase (4.3 mM) was equilibrated for 30 min
with 10 or 100 mM of ligands in buffer-A (50 mM N-glycylglycine
and 10 mM MgSO4, pH 7.8), with or without 2 mM ATP. For
each condition (1 or 2), the prepared reaction mixture was
distributed in three wells of a 96-well glass plate (Zinsser Analytic,
Northridge, CA) kept on ice to protect from thermal side reactions
and irradiated for 30 min at 365 nm with a Black-Ray UV lamp
(model UVL-56 Upland, CA) at a distance of ,1 cm. Photola-
beling was quenched with an equal volume of 2X SDS-PAGE
sample loading buffer. The photolabeled protein was separated
from the reaction mixture by SDS-PAGE.
For time-resolved photolabeling of luciferase at 200 ms after
addition of ATP, we adapted a method from the time-resolved
photolabeling of Torpedo californica nicotinic receptor as previously
described [21]. Briefly, the loop of one of the two six-way sample
valves was filled with 0.5 mL of purified recombinant luciferase
(4.3 mM) equilibrated with the photolabels in buffer-A. The other
six-way sample valve’s loop was filled with 0.5 mL of the
photolabels in buffer-A with or without 2 mM of ATP. The
contents of the loops were forced through the rapid mixer (,1 ms)
by a pneumatic pump and then incubated in an appropriate aging
loop for ,200 ms and expelled onto a rotating stainless steel disk
(60 rpm) pre-cooled in liquid nitrogen, where they were
instantaneously (,1 ms) frozen in a thin film. The freeze-
quenched samples were then irradiated for 30 min at 365 nm as
above on the slowly rotating disk (3 rpm) in contact with liquid
nitrogen before being melted into sample buffer as above. Three
replicates were acquired for each set of conditions, and all
experiments were repeated on a separate day.
To quantify photolabel incorporation, luciferase was incubated
with [
3H]3-azioctanol alcohol and the amount of radioactivity
Figure 1. The structure of Japanese luciferase. A. The backbone
structure of the highest resolution structure (2D1S.pdb) is shown in
ribbon format. The lid domain is shown in gold. The two ligand–binding
sites are indicated with arrows and are shown occupied by the
concatenated active state analog DSLA. B. The benzothiazole ring of
oxyluciferin and DSLA are isosteric. The structures of Japanese luciferase
with oxyluciferin +AMP bound (2D1R.pdb) and with the concatenated
active state analog DSLA bound (2D1S.pdb) were superimposed. The
backbone structures overlay exactly in this region and only that for
2D1R is shown. The ligands’ atoms are color coded normally except
carbons, which are goldenrod for DSLA and yellow for oxyluciferin and
AMP.
doi:10.1371/journal.pone.0029854.g001
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alcohols, the luciferase band from each sample was visualized by
Coomassie blue stain, the band was excised, transferred to tubes
containing ,4 mL of gel solubilizer, allowed to stand until the
count was stable (typically for 6 days) at room temperature, and
assayed by scintillation counting (1900 CA, Tri-Carb, Liquid
Scintillation Analyzer, Canberra Packard Instruments Co.,
Downers Grove, IL). The background radioactivity due to
unreacted [
3H]3-azioctanol label present in the gel was measured
from the sections lacking protein below the protein band.
In-gel proteolytic digestion
In-gel proteolytic digestion was carried out following the
method of Shevchenko and Shevchenko [22] to ensure that
protein was free from small molecule impurities prior to
submission for mass spectrometry analysis. Approximately 10 mg
of photolabeled firefly luciferase was separated from other
materials by SDS-polyacrylamide gel electrophoresis in a 10%
polyacrylamide gel. The Coomassie blue stained luciferase band
was cut into ,2 mm squares, incubated overnight at room
temperature with 200 mL of 50 mM ammonium bicarbonate
solution, and then washed with acetonitrile for 10 min. The
solvent was removed under vacuum, and the gel pieces were
rehydrated with aqueous 50 mM ammonium bicarbonate solution
containing 12.5 ng/mL modified sequencing-grade trypsin at 4uC.
After 45 min of digestion, the excess proteolysis solution was
removed and replaced with a volume of 50 mM ammonium
bicarbonate solution sufficient to cover the gel for 16–20 hrs
overnight incubation at 37uC. Peptides were then extracted from
the gel pieces by first removing the ammonium bicarbonate
solution and then performing two consecutive 20 min incubations
in a solution composed of 50% v/v acetonitrile and 5% v/v formic
acid. The extracts were combined, dried under vacuum for ,1h
and stored at 4uC until analysis.
Stopped-flow kinetic studies
Stopped-flow kinetic experiments were performed with a BioS
X-17 MV spectrofluorimeter (Applied Photophysics, Leatherhead,
England). Light output was monitored without filtration. All
experiments were carried out in buffer-A at 2261uC. ATP (2 mM;
final concentration) was rapidly mixed with luciferase (20 nM) that
had been pre-incubated with luciferin (28 mM) and appropriate
concentrations of 3-azioctanol for 30 min. The burst of light for
each condition was recorded; the slope of the linear region of the
curve was used to characterize the level of the luciferase activity.
Tandem HPLC and mass spectrometry
LC-MSMS experiments were performed on an Orbitrap mass
spectrometer (ThermoElectron, Waltham, MA). This is a fully
integrated hybrid mass spectrometer consisting of a linear ion trap
mass spectrometer combined with a Fourier transform ion
cyclotron resonance mass spectrometer. A nanoscale reverse-
phase HPLC capillary column was created by packing 5 mm C18
spherical silica (pore size 200 A ˚) into a 12 cm fused silica capillary
tube of 125 mm inner diameter with a flame-drawn tip fabricated
in-house. Peptides stored after trypsin digestion were reconstituted
in 5 mL of an aqueous solution composed of 2.5% v/v acetonitrile,
0.1% v/v formic acid and were eluted by a linear concentration
gradient (acetonitrile with 0.1% formic acid increasing from 10 to
38% over 30 min followed by a step increase to 100%).
Each eluted peptide was subjected to electrospray ionization.
The m/z of each isolated peptide was determined to high accuracy
by Fourier transform mass spectrometry (FTMS). The remainder
of the sample was fragmented by collision with an inert gas and its
tandem mass spectrum (MSMS) was analyzed to determine its
sequence using the top down method. After a full MS scan, the top
ten most intense peaks were selected for MSMS analysis with a
range of 1.5 m/z and with dynamic exclusion on. The position of
photoincorporation was determined using the Bioworks browser
3.1 module of the program Xcalibur (ThermoElectron, Waltham,
MA).
Peptide fragments will only be detected if they are charged. For
cleavage at the peptide bond, when this charge is retained on the
N-terminal or C-terminal fragment, the ion is called a b-ion or a y-
ion respectively (http://www.ionsource.com/tutorial/DeNovo/
DeNovoTOC.htm).
Molecular modeling
Figures shown in this manuscript were modeled in the program
Chimera using structures downloaded from the remediated pdb
(http://www.rcsb.org/pdb/home/home.do). To model ethylene
glycol in the luciferase vestibule (Fig. S4), we downloaded
3IEP.pdb and its electron density map from the Protein Data
Bank into the program Coot [23]. We generated the coordinates
of ethylene glycol using the SMILES string C(CO)O, and visually
placed it in the excess density using the translate and rotate
functions in Coot.
Results
Inhibition of luciferase activity by 3-azioctanol
In order to assess whether 3-azioctanol, like octanol and other
alkanols, inhibits luciferase, American firefly luciferase (20 nM)
was pre-incubated for 15 minutes with 0 to 6000 mM 3-azioctanol
in the presence of 28 mM luciferin at 2261uC. These samples were
then rapidly mixed with 4 mM ATP in the stopped flow
spectrofluorimeter. Final concentrations were half those given
above. The light emitted was monitored for 5 s. It showed an
initial lag of ,50 ms, rose to a peak at ,300 ms and fell slowly for
5 s (Fig. 2A). Increasing concentrations of 3-azioctanol reduced
the maximum light output without altering the overall pattern of
time–dependence. We used the slope of the linear region of the
kinetic curve (,65 to ,200 ms) as a measure of inhibition. The
data were normalized between the control and 3000 mM slopes
and fitted to a logarithmic equation by nonlinear least squares
(Fig. 2B) to yield an IC50 of 200646 mM and a slope of 1.060.2.
For comparison, the general anesthetic EC50 for 3-azioctanol is
160 mM [20]. Under similar conditions, 225 mM 1-octanol
inhibited luciferase by ,50%. This compares to a reported IC50
of 280 mM for 1-octanol [16]. 3-Azibutanol (1 mM) also inhibited
luciferase. Thus, azialkanols behave like other 1-alkanols with
respect to inhibition of luciferase.
Equilibrium photolabeling of luciferase by [
3H]3-
azioctanol
Because the inhibition of luciferase activity by alcohol is ATP-
dependent [16], we determined the effect of ATP on the
photoincorporation of [
3H]3-azioctanol. Increasing concentrations
of [
3H]3-azioctanol were preincubated for 30 min with 4.3 mM
Japanese firefly luciferase in the absence or presence of 2 mM
ATP, and photolabeled as described above. In the presence of
ATP, the level of photoincorporation increased linearly (Fig. 3),
consistent with either a nonspecific action or binding to sites with
very low affinity. In the absence of ATP, photoincorporation was
higher at all alcohol concentrations and the shape of the curve
suggested saturable binding with a dissociation constant above
1 mM. Similar data were obtained with American firefly
General Anesthetic Inhibitory Sites on Luciferase
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of [
3H]3-azioctanol into firefly luciferase.
Time resolved photolabeling with [
3H]3-Azioctanol
At first sight the ATP-induced decrease in photoincorporation
of [
3H]3-azioctanol observed above contradicts the allosteric
hypothesis of Moss et al [16], which predicts that ATP induces a
higher affinity binding of alcohols. However, their hypothesis
refers to the initial phase of the reaction (#300 ms), not at
equilibrium. Accordingly, we determined photoincorporation into
luciferase 200 ms after the addition of 2 mM ATP using time
resolved photolabeling. Because of the large sample size required
by the apparatus and the cost of tritiated ligands, only a single
concentration of [
3H]3-azioctanol (1 mM) was examined. The data
presented in Fig. 3 (inset) show that, unlike at equilibrium, ATP
doubles the photoincorporation of [
3H]3-azioctanol into luciferase
at 200 ms. Analysis of the data by the Student’s t-test yielded a p-
value of 0.002 indicating that the difference in photoincorporation
observed without ATP (white bar) and with ATP (black bar) is
statistically significant.
Identification of residues photolabeled in luciferase
To identify residues in the anesthetic binding site(s), we
photolabeled Japanese luciferase in both the presence and
absence of ATP (at 200 ms and at equilibrium) with the
diazirinyl n-alkanols (3-azibutanol, 3- and 7-azioctanol) and with
TFD-benzyl alcohol. All samples were proteolytically digested
and subjected to HPLC-MSMS. We were able to sequence 94%
of the Japanese luciferase, but our data (see below and Tables 1 &
2) show that photolabeling is confined to a few major peptides
together with a number of nonspecific sites. Furthermore, to
enhance our ability to map the binding sites we used both
aromatic and aliphatic alcohols containing diazirine groups
because these two classes of agent have different photoselectiv-
ities. Although no formal survey has been published, aromatic
and aliphatic diazirines react selectively with nearly complemen-
tary sets of residues (roughly Leu, Ile, Ser, Met Val, Phe vs. Tyr,
Glu, Asp, His, Met, respectively) [24].
We also photolabeled the American firefly luciferase at
equilibrium with the azialkanols, and found the labeling pattern
to be identical. The American and Japanese firefly luciferases have
both been used in anesthetic studies; the American has been
studied extensively, but the highest resolution structure is for the
Japanese. Overall, these two proteins are highly homologous
(67%), and we have used the Japanese numbering system in this
discussion (for the residues of interest, subtracting 2 from the
Japanese residue number usually gives that of the American). The
two luciferases sometimes differ in their proteolytic cleavage
patterns, and we have found this useful (see below).
Figure 2. The 3-Azioctanol inhibits ATP-induced luciferase
activity. Fresh American firefly luciferase pre-incubated with luciferin
and increasing concentrations of the alkanol were rapidly mixed with
ATP (see Results). A. Increasing concentrations of 3-azioctanol inhibited
the initial phase of light emission. B. The slope of the linear portion of
the initial peak of each curve was normalized (see Results) and plotted
against the 3-azioctanol concentrations. Nonlinear least squares fitting
yielded an IC50 value of 220647 mM and a Hill coefficient of 1.160.2.
doi:10.1371/journal.pone.0029854.g002
Figure 3. ATP modulates the photoincorporation of [
3H]-3-
Azioctanol into luciferase at equilibrium. Increasing concentra-
tions of [
3H]3-azioctanol were preincubated for 30 min with 4.3 mM
Japanese firefly luciferase in buffer-A containing 0 (%)o r2m M( &)
ATP, photolabeled and analyzed as described in the text. Each sample
was prepared in triplicate and each point represents the mean and
standard deviation. Where error bars are not shown, they are smaller
than the symbol. Inset: Luciferase (4.3 mM) pre-incubated with 1 mM
[
3H]3-azioctanol was rapidly mixed with buffer-A containing 0 (white
bar) or 2 mM (black bar) ATP, freeze-quenched after 200 ms and
photolabeled (see text). Three shots were acquired for each set of
condition and the bars represent the mean and the error bars the
standard deviation.
doi:10.1371/journal.pone.0029854.g003
General Anesthetic Inhibitory Sites on Luciferase
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The Japanese luciferase was exposed to ATP and 100 mM3 -
azioctanol for 200 ms, rapidly frozen and photolabeled. The
samples were treated as described in Methods, and the tryptic
fragments analyzed by HPLC-MSMS. A doubly charged peptide
of mass 1963.1679 Da with a retention time of 29.1 min was
detected by FTMS. This peptide was identified as the 18–residue
peptide YDLSNLVEIASGGAPLSK beginning at Y306 and
incorporating a single molecule of azioctanol. It was fragmented
by collision with an inert gas to yield peptide fragments with an
intact N-terminus, called b-ions, or an intact C-terminus, called y-
ions. Fig. 4A shows the MSMS spectrum that was used to identify
the point of photoincorporation as Glu-313. A sequence of mostly
strong singly charged y-ions from y15 to y4 was observed with a
loss of 3-azioctanol between y11 and y10. This conclusion was
consistent with the b-ion pattern where a run of peaks was
observed from b14 to b6 (except b12), with loss of 3-azioctanol
between b8 and b7. This assignment had an Xcorr value of 5.9
(Table 1). Similar results were obtained for Japanese luciferase
labeled with 100 mM 7-azioctanol and 1 mM 3-azibutanol at
equilibrium in the absence of ATP (Table 1; Figs. S1 & S2). The
percent of observed peptides that were labeled was 25–50% at
Table 1. Residues photolabeled in a tryptic fragment of Japanese Firefly Luciferase (306-YDLSNLVEIASGGAPLSK-323)
a identified
by LTQ–FT mass spectrometry and MSMS.
Agent Alcohol mM ATP Time ms Residue Photolabeled Charge Rt, min Xcorr
bMH
+ Accuracy
cppm
Parent peptide
d +2 24.0 6.0 1835.05 0.91
7-azioctanol 100 + 200 E313
f +2 31.2 5.5 1963.17 0.79
100 2‘ E313 +2 26.1 5.4 1963.17 0.79
100 + ‘ Photolabeled peptide rarely detected
3-azioctanol 100 + 200 E313 +2 29.1 5.9 1963.17 0.79
100 2‘ E313 +2 28.1 5.4 1963.17 0.79
100 + ‘ Photolabeled peptide rarely detected
3-azibutanol 1000 + 200 E313
f +2 26.6 5.6 1907.05 0.91
1000 2‘ E313 +2 23.5 6.1 1907.05 0.91
1000 + ‘ Photolabeled peptide not detected
TFD-benzyl alcohol 100 + 200 I314 +2 30.5 4.4 2022.00 1.96
100 + 200 S316 +2 29.3 5.4 2022.00 1.96
100 2 200 I314 +2 31.2 5.6 2022.00 1.96
aPhotolabeled residues are indicated in bold.
bRepresentative observed masses that include increases due to photolabeling by 3-azioctanol and 7-azioctanol (128 Da) or 3-azibutanol (72 Da) or TFD-benzyl alcohol
(188 Da).
cAccuracy is the difference between the calculated and observed mass expressed in ppm.
dParent peptides are those derived from that fraction of Luciferase in a given run that was not photolabeled during an experiment with azialcohols or TFD-benzyl
alcohol. See ‘‘Materials and methods’’ section for other details.
doi:10.1371/journal.pone.0029854.t001
Table 2. Residues photolabeled in a tryptic fragment of Japanese Firefly Luciferase (340-QGYGLTETTSAIIITPEGDDKPGASGK-366)
an
identified by LTQ–FT mass spectrometry and MSMS.
Agent Alcohol mM ATP Time ms
Residue
Photolabeled Charge Rt, min Xcorr
bMH
+ Accuracy
cppm
Parent peptide
d +3 25.8 5.5 2707.93 0.58
7-azioctanol 100 + 200 Photolabeled peptide not detected
100 2‘ D358 +3 21.8 6.0 2836.05 0.70
100 + ‘ Photolabeled peptide rarely detected
3-azioctanol 100 + 200 Photolabeled peptide not detected
100 2‘ D358 +3 22.7 5.5 2836.05 0.70
100 + ‘ Photolabeled peptide not detected
3-azibutanol 1000 + 200 D358 +3 20.3 5.8 2779.93 0.58
1000 2‘ D358 +3 17.3 6.2 2779.93 0.58
1000 + ‘ Photolabeled peptide not detected
TFD-benzyl alcohol 100 + 200 S349
e +3 24.8 5.0 2894.39 0.96
a–dSame as Table 1.
ePhotoincorporation was either in Ser-249 or Ala-250. The latter residue is rarely labeled by aromatic diazirines.
doi:10.1371/journal.pone.0029854.t002
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reduced this to 0–10%. At equilibrium, photolabeling of Glu-313
could be resolved at concentrations as low as 10 mM 3-azioctanol
(Fig. S3) and 100 mM 3-azibutanol.
When Japanese luciferase was photolabeled with 100 mM TFD-
benzyl alcohol after incubation for 200 ms with ATP, a major
photolabeled trypsin product that eluted from the HPLC at
29.3 min was a doubly charged peptide of mass 2021.9993 Da. It
was identified as an 18–residue peptide YDLSNLVEIASG-
GAPLSK, starting at Y306, photolabeled by a single TFD-benzyl
alcohol. Fig. 4B shows the MSMS spectrum that was used to
identify the point of photoincorporation as Ser-316. A sequence of
mostly strong singly charged y-ions from y15 to y4 with the
exception of y7 was observed with a loss of TFD-benzyl alcohol
between y8 and y6. This result is consistent with the b-ion pattern
where a run of peaks was observed from b17 to b5 with the
exception of b11, with loss of TFD-benzyl alcohol between b12
and b10. Thus, the photolabeled residue is Ser-316. This
assignment had an Xcorr value of 5.39 (Table 1).
From the same experiment, another tryptic peptide, eluting a
little later (30.5 min), was doubly charged with the same mass of
2021.9993 Da, but it was not photolabeled at Ser-316. The
MSMS spectrum shows a run of mostly strong singly charged y-
ions from y14 to y4 with a loss of TFD-benzyl alcohol between y10
and y9, placing the site of photoincorporation at Ile-314 (Fig. 4C).
This conclusion was consistent with the b-ion pattern where a run
of peaks was observed from b6 to b14, with loss of TFD-benzyl
alcohol between b9 and b8. This assignment had an Xcorr value of
4.43 (Table 1). Consistent with our observation that TFD-benzyl
alcohol photolabeled both Ile-314 and Ser-316, we found that
double labeling predominated over single labeling by fourfold with
+ATP at 200 ms, but the quality of these double labeled spectra
were inadequate to resolve their sites of photoincorporation. The
frequency of photoincorporation was lower than with the
azialkanols, consistent with the known low photolabeling efficiency
of aromatic diazirines, making it difficult to resolve small change in
photoincorporation, but simultaneous addition of both ATP and
luciferin completely abolished photoincorporation into both
residues.
Residues photolabeled on peptide Gln-340 – Lys-366
A second peptide that was photolabeled was a 27–residue
tryptic peptide starting at Gln-340. Sequencing this peptide proved
to be difficult. Neither digestion by chymotrypsin nor Asp-N
produced a better situation. In some cases we could not
unambiguously define the point of incorporation. When Japanese
firefly luciferase was photolabeled with 1 mM 3-azibutanol after
incubation for 200 ms with ATP, a triply charged tryptic peptide
eluted from the HPLC at 20.3 min with a mass of 2779.9283 Da
by FT–MS, corresponding to a photolabeled 27–residue peptide
starting at Q340—QGYGLTETTSAIIITPEGDDKPGASGK.
The MSMS spectrum of this peptide is shown in Fig. 5A. A
sequence of doubly charged y-ions from y24++ to y9++, with the
exception of y11++, was observed to be modified, suggesting that
the fragment 358–DDKPGASGK is photolabeled. Consistent
with this, a run of weaker singly charged y-ions was observed from
y13 to y6, with the exception of y9. In this series all ions are
modified except for y8, y7 and y6, narrowing the assignment of the
photolabeled residue to Asp-358. The assignment based on the y+
ions is somewhat insecure because of their low amplitude. Thus,
the evidence ruling out Glu-356 as a site of photolabeling rests on
the large doubly charged y9++ and y10++ ions. The b ions had
low intensity and were not used in this analysis. This assignment
had an Xcorr value of 5.8. Under the same conditions when
luciferin was included no photolabeled peptides were observed.
Tryptic digestion of Japanese luciferase photolabeled with
100 mM TFD-benzyl alcohol after incubation for 200 ms with
ATP yielded a triply charged photolabeled peptide of mass
2894.3869 that eluted at 24.8 min. It was identified as the same
peptide as above, starting at Gln-340, photolabeled by a single
TFD-benzyl alcohol. A complete series of doubly charged y-ions
from y25++ to y19++ were all modified (Fig. 5B). Another series of
y++ ions from y16++ to y12++ were unmodified. Thus,
photoincorporation must be in either Ser-349 or Ala-350. This
assignment is consistent with the weaker run of unmodified y+ ions
from y16 to y12 and from y8 to y5. Based on a large body of
photolabeling data with aromatic diazirines, in particular 3-
(trifluoromethyl)-3-(m-iodophenyl) diazirine (TID), alanine has a
very low probability of being photolabeled, so we conclude that
Ser-349 is the residue photolabeled by TFD-benzyl alcohol. When
luciferin and ATP were added simultaneously for 200 ms there
was no photoincorporation into this peptide.
Residues photolabeled on peptide Cys-284 – Lys-299
In the time resolved experiments with 100 mM TFD–benzyl
alcohol, the 16–residue peptide CTSVILVPTLFAILNK eluted at
,25 minutes as a doubly charged ion with molecular weight of
2296.1277 Da by FT–MS. Unfortunately, it proved very difficult
to sequence this peptide reliably. The best sequence (Xcorr=1.75)
was observed for a triply labeled peptide in a run with ATP
exposure for 200 ms. In a series of doubly charged y-ions, from
y15++ to y10++, with the exception of y12++, one photolabel was
lost between y14++ and y13++ and a second between y13++ and
y11++. The final photolabel was still attached at y6++,y 5 ++ and
y4++, but likely not at y2+ (Fig. 6A). This data is consistent with
photoincorporation at Ser-286, Ile-288 as well as at one of the C-
terminal residues, 297–LNK. Of these three residues, photo-
selectivity favors Leu-297 and y2+ probably rules out Lys-299.
This assignment of labeling was typical of many other lower
quality spectra. Photoincorporation into this peptide was much
more efficient (,56) than into the peptide in the previous section.
It was often observed with 2 or 3 TFD–benzyl alcohol molecules
photoincorporated.
Residues photolabeled on peptide Asp-226 – Arg-263
This peptide was rarely seen when the Japanese luciferase was
sequenced, but was observed in the American luciferase, possibly
because 6 residues are not conserved. When American firefly
luciferase was photolabeled with 1 mM 3-azibutanol after
incubation for 200 ms with ATP, a quadruple charged tryptic
peptide eluted from the HPLC at 32.5 min with a mass of
4266.1344 Da by FT–MS, corresponding to a photolabeled 38–
Figure 4. Identification of photolabeled residues in the peptide Tyr-306– Lys-324. The site of photoincorporation of photolabels was
inferred from these MSMS spectrum. In the insets, the predicted charge/mass ratios of ions with an intact N-terminus (b-ions) or C-terminus (y-ions)
are shown above and below the sequence, respectively, with the indicated charge. The photolabeled residue is boxed and the experimentally
observed values are colored (b-ions in red and y-ions in blue) and in bold and their position indicated on the spectrum. Luciferase was photolabeled
after exposure to ATP (2 mM)+photolabel for 200 ms. A. 3-azioctanol (100 mM) photolabels Glu-313. B. TFD-benzyl alcohol (100 mM) photolabels Ser-
316. C. TFD-benzyl alcohol (100 mM) photolabels Ile-314.
doi:10.1371/journal.pone.0029854.g004
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GYLICGFR starting at Asp-226. This long peptide with 5 glycine
and 3 proline residues was difficult to sequence entirely. A run of
y-ions that all include a photolabel from y26++ to y12++ with the
exception of y18++, y17++ and y14++, suggest that the photolabel
is on one of the 12 residues at the N-terminal end of the peptide
(Fig. 6B). A fairly complete run of modified b-ions from b28+++ to
b36+++ except b30 & 33+++ with loss of label between b32+++
and b34+++, together with unmodified b33++++ and b34++++
ions is consistent with photoincorporation on Tyr-257. Although
some of these peaks are small, this conclusion is reinforced by the
fact that Tyr-257 is the only residue in the N-terminal dozen
residues that aliphatic diazirines have been observed to react with
[24].
Minor labeling sites
A number of other peptides were photolabeled in an ATP–
independent manner by azialkanols. These residues were invari-
ably on the surface. For example, in a time–resolved photolabeling
experiment with 1 mM 3-azibutanol in the presence of ATP and
luciferin, luciferin–independent photolabeling was seen in the lid
domain, primarily in Glu-499 and Tyr-304, and in a surface
residue, Tyr-58. None of these residues are near the known
binding sites for ATP or luciferin, and they were not photolabeled
at 10 mM 3-azioctanol or 100 mM 3-azibutanol, so they represent
low affinity nonspecific photoincorporation. Another surface
residue, Tyr-18, was photolabeled by 1 mM 3-azibutanol in the
absence but not presence of ATP. It was also observed at 10 mM3 -
azioctanol and 100 mM 3-azibutanol, concentrations at which the
other surface residues were not seen.
Anesthetic potency
Loss of righting reflex was determined over the concentration
range 5–100 mM TFD-benzyl alcohol. All animals recovered from
anesthesia. The EC50 for loss of righting reflexes was 2866.7 mM
and the slope was 2.160.76.
Discussion
Conformation–dependent photoincorporation
3-Azioctanol inhibited the initial light emitting reaction of
luciferase following the addition of luciferin and ATP, resembling
other alkanols in this respect [16,25]. It had an IC50 of 200 mM
and a Hill coefficient of one (Fig. 2A & B). At equilibrium, the
concentration dependence of overall photoincorporation of [
3H]3-
azioctanol into luciferase increased linearly with concentration in
the presence of ATP, suggesting low affinity nonspecific binding,
but in the absence of ATP it increased in a saturable manner
suggesting interaction with one or more binding sites (Fig. 3). The
latter interaction was of comparatively low apparent affinity
(,1 mM) compared to the IC50 for inhibition of the initial light
emitting reaction (Fig. 2B). However, total photoincorporation of
[
3H]3-azioctanol more than doubled when ATP was added for
only 200 ms. These observations suggest that when ATP interacts
with apo-luciferase in the first few 100–milliseconds it converts the
low affinity alcohol site into a site of higher affinity, but that it
subsequently drives a conformation change that dramatically
reduces the affinity of the site for alcohols (affinity increases in the
order: ATP at equilibrium,no ATP,ATP at 200 ms).
Sequencing revealed a number of surface residues that were
photolabeled in an ATP-independent manner (Results), as well as
buried residues in which photolabeling was state dependent. The
most robust ATP–dependent photoincorporation of azialkanols
occurred at Glu-313 (3-azibutanol, 3- and 7-azioctanol) (Fig. 4A,
5B and S1). The modified peptide could be detected when
luciferase was photolabeled at equilibrium in the absence of ATP
at concentrations as low as 10 mM 3-azioctanol (Fig. S3) and
100 mM 3-azibutanol, concentrations at which all but one of the
surface residues were not photolabeled. Although the sampling
logic of the mass spectrometer prevents quantitative interpretation,
the conditions of these experiments were all very similar so a
qualitative comparison of the state–dependence of photoincor-
poration can be made by considering the frequency with which
Glu-313 was observed to be photolabeled. The ranking of
photoincorporation into Glu-313 in the three states is similar to
that observed for [
3H]3-azioctanol into luciferase itself (ATP at
equilibrium,no ATP,ATP at 200 ms). Taken together with the
observation that photoincorporation into Glu-313 tended to be
reduced in the presence of luciferin, this evidence suggests that
Glu-313 may be directly involved in alcohol inhibition of
luciferase. Photoincorporation of TDF-benzyl alcohol into lucif-
erase occurred at too low a frequency to reliably assess ATP–
dependence.
Most of the surface residues showed no conformation
dependence. However, there were two exceptions. First, azialk-
anols photolabeled Asp-358 in an ATP-dependent manner. The
pattern of photolabeling was unusual. It was only observed in the
absence of ATP, and unlike Glu-313, exposing to ATP for 200 ms
abolished photolabeling by the azioctanols. The only exception
was azibutanol that did photolabel after 200 ms of ATP exposure,
and luciferin then abolished photolabeling. Asp-358 is a surface
residue beyond the extension of the luciferin pocket that contains
Glu-313 (its a-carbon is 11 A ˚ from the e-oxygen of Glu-313 A ˚).
When the +DSLA (59-O-[N-(dehydroluciferyl)- sulfamoyl]adeno-
sine) and +ATP structures are superimposed, the position of the
alpha carbons of Asp-358 are seen to differ by nearly 1 A ˚.
Moreover, this region of the protein exhibits high b-factors
(temperature factors) in all reported structures, suggesting
considerable inherent mobility. Thus, this surface pocket appears
to be sensitive to conformation but is unlikely to be involved in
inhibition by alcohols. The second exceptional residue, Tyr-18,
lies on the N-terminal strand that traverses the surface of
luciferase. In all the published structures, the Ca of Tyr-18 has
the same position, but in the bromoform bound American
luciferase structure (1BA3.pdb) its side chain adopts a different
rotamer. The crystal structures provide no explanation for the
behavior of this residue. It remains possible that this part of
luciferase adopts a different conformation in solution.
Photolabeled sites in the luciferin–binding pocket
The location of photolabeled residues can be discussed in the
context of several crystal structures [10,11,12,17]. Of these, that of
Japanese luciferase determined by Nakatsu et al [11] is the most
complete, has the highest resolution, and was determined with
various ligands bound [11], although they were unable to obtain
crystals of the apo state. Of course, there is no crystal structure of
the short-lived conformation we captured by photolabeling at
200 ms after adding ATP, but it is claimed that the concatenated
ligand DSLA (Fig. 1B) that occupies both the luciferin and ATP
Figure 5. Identification of photolabeled residues in the peptide Gln-340 – Lys-366. Conditions are as in Fig. 4. A. 3-azibutanol (1 mM)
photolabels Asp-358. B. TFD-benzyl alcohol (100 mM) photolabels Ser-349.
doi:10.1371/journal.pone.0029854.g005
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bound has by far the highest resolution (1.3 A ˚) of all published
structures, and we will discuss the location of the photolabeled
residues with respect to it (2D1S.pdb). The position of oxyluciferin
in the binding pocket (2D1R.pdb [11]) is isosteric with the
benzothiazole ring of DSLA (Fig. 1B). DSLA, regarded as a high-
Figure 6. Identification of photolabeled residues in two peptides. Conditions are as in Fig. 4. A. TFD–benzyl alcohol (100 mM) photolabels
Ser-314 in the peptide Cys-284 – Lys-299. B. 3-azibutanol (1 mM) photolabels Tyr-257 in the peptide Asp-226 – Arg-263.
doi:10.1371/journal.pone.0029854.g006
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site, in which its benzothiazole ring is tightly sandwiched in a
hydrophobic pocket, whereas the states before and after the
reaction are in an open form [11].
At the competitive inhibition site within the luciferin–binding
pocket, the photolabeled Ser-349 and Ser-316 are 10 A ˚ apart and
contact the benzothiazole ring of DSLA on opposite sides (Fig. 7A).
The hydroxylofSer-349is ,4A ˚ from the benzothiazolering (N7&
C2) and hydrogen bonds to N7 through an intermediate water
(Fig. 7A, upper inset). The backbone carbonyl of Ser-316 is 3.8 A ˚
from the C5 of the benzothiazole ring and 3.9 A ˚ from its terminal
oxygen (O10). C-terminal from Ser-316 (316–SGGAAPL–321), the
backbone makes a hairpin turn at the second of the two glycines
(Gly-318), which is in contact with both the adenosine ring of ATP
and the benzothiazole ring of DLSA (not shown). Indeed, the
separation of O10 of the benzothiazole ring from N37 of the
adenosine ring is only 7.6 A ˚. In the +ATP structure, this strand has
poor electron density and high b-factors, but once both binding
pocketsareoccupiedtheelectrondensityimprovesdramaticallyand
theb-factorsfall.Thus,ligand bindinginducesimportant changesin
this turn, coupling the two binding pockets. Our emphasis on the
dynamics in this region is supported by simulations using Gaussian
and anisotropic network models that predict that anesthetics cause
an increase in flexibility in this region [26].
Allosteric action can occur because the luciferin–binding pocket
is not completely filled by luciferin or the benzothiazole ring of
DSLA (Fig. 7B & C). The total length of the pocket is some 20 A ˚,
and an unoccupied vestibule, 6–7 A ˚ long extends beyond DSLA’s
terminal oxygen (O10). The vestibule is wider and has a more
irregular shape than the luciferin–binding region. Ser-286 and Ile-
288, which are likely photolabeled by TFD-benzyl alcohol, lie
close to Glu-313. Together with the photolabeled Tyr-257, they
line much of one side of the vestibule. As has been pointed out
[11], the exact spatial relationship between these three residues
varies with the conformation of luciferase. Upon activation, the
side chain of Ile-288 rotates and moves towards luciferin, helping
to create a tightly packed hydrophobic environment for light
emission, and Ser-286 releases its hydrogen bond with Glu-313,
and instead hydrogen bonds to Tyr-257 via a water molecule
(Fig. 7A, lower inset). In consequence, a network of hydrogen
bonds involving five water molecules couples Asn-231, Tyr-257,
Glu-313, Ser-286 and the O10 oxygen of DSLA. Recent
theoretical calculations of the activated state of luciferin have
placed an emphasis on the state of the O10 of luciferin and its
associated hydrogen–bonded network of water molecules whose
configuration depends on the orientation of the surrounding
residues including Glu-313 [27,28]. The allosteric action of
anesthetics on luciferase, which is revealed at high luciferin
Figure 7. The structure of Japanese luciferase in the vicinity of the main photolabeled residues. The structure is shown as a cross section
through the luciferin pocket with DSLA bound in the luciferin and ATP sites (2D1S.pdb). Panel A shows a close up view. Panel B is the same view
zoomed out (note the 10 A ˚ scale bars) to show the luciferin and ATP pockets. Panel C was obtained by rotating panel B 180u on the y-axis without
scaling, viewing the pocket from the opposite side. Cross sections through the protein are capped in white mesh, revealing the residues behind.
DSLA is shown with golden carbons. The main photolabeled residues are shown in ball & stick representation with cyan carbons; note that Ser-316
shows two rotamers with each oxygen assigned half occupancy. Important residues for the activity of luciferase that may have been photolabeled are
shown with green carbons in stick representation. Hydrogen bonds to ligands and water are shown in panel A by green dashed lines. Surface colors
are: white, carbon (except for photolabeled residues, cyan or green); blue, nitrogen; red, oxygen. The upper inset in panel A shows the interaction
between Ser-349 and DSLA and the hydrogen bonded water. The lower inset shows the hydrogen bonding network linking the major residues
interacting with DSLA through water molecules. Hydrogen bonds shown range from 2.5 to 3.0 A ˚ in length.
doi:10.1371/journal.pone.0029854.g007
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as well as rearrangement of surrounding residues.
In addition, Glu-313 is in the interface between the vestibule
and a complex surface pocket, which we will call the grotto
(Fig. 7B). The vestibule and grotto are separated by the side chains
of a number of residues in the activated, DSLA–bound state, but
in the equilibrium +ATP state, the above rearrangements open up
the vestibule to the grotto (Fig. 8), perhaps contributing to the
lower affinity for anesthetics in this state.
Nature of the anesthetic binding pocket
The region close to the benzothiazole ring of DSLA in the
luciferin pocket is largely apolar on one side, with Ile-288 and Phe-
249 underlying the ring (Fig. 7B). The other half of the surface is
more polar, being exposed to the backbone of the strand 341–
GYGL–344 and to the side chain of Ile-253 (Fig. 7C). In the
vestibule, polar residues predominate. This mix of polarity is
expected for general anesthetic binding pockets in proteins [29].
The vestibule in the DSLA structure is filled by eight water
molecules, whereas in the +ATP structure (2D1Q.pdb) it contains
only 4 water molecules (Fig. 8). These waters are category two
waters in the Ringe classification, meaning that they are observed
in some but not all conformations of the protein [30], and their
displacement by an anesthetic would more than offset the entropic
cost of confining the anesthetic to the binding pocket. Because
there are more waters in the DSLA ‘‘active’’ structure than in the
+ATP structure, the entropic contribution from their displacement
would favor binding to the former state, as is observed (Fig. 2). A
similar ratio of waters is found when the active and Apo structures
of the American luciferase are compared (3IES.pdb vs. 3IEP.pdb).
Thus, the conformation with the most hydration in the vestibule is
also the one with highest affinity for alcohols.
A survey of structures with anesthetics bound, concludes in
addition, that some waters may remain in the pocket and
compensate for imperfectly fitting anesthetics [29]. Such a
mechanism might allow the pocket and vestibule to accommodate
ligands of variable structure, which would be consistent with the
wide range of agents that inhibit luciferase [7,9,25,31]. Indeed,
even the oxyluciferin– and DSLA–occupied pockets contain a
water molecule hydrogen–bonded to Ser-349 and the benzothia-
zole ring’s nitrogen.
A feature of many of the photolabeled residues (shown as bold)
is their proximity to small residues, such as glycine and alanine,
that permit some local flexibility (312 –VEIASGGA–; 347 –
TSAI–; 357–GDDK–; 256–GYLI–; for clarity alanine and glycine
are marked in blue). Crystallography provides the mean
equilibrium location of atoms usually at liquid nitrogen temper-
ature, but at physiological temperatures and in solution consid-
erably more motion must occur. A measure of relative mobility
within the crystal is given by the b-factors, which tend to increase
as one moves from residues proximal to DSLA to those in the
vestibule and beyond that into the grotto region. For example, the
side chain b-factor of Ser-349 next to DSLA is 4 A ˚ 2 whereas those
of Glu-313 and of Asp-358 in the same structure are respectively
13 A ˚ 2 and 19 A ˚ 2. Furthermore, mobility can vary with the state
induced by ligand binding. For example, in the DSLA bound state,
the electron density of the residues following Glu-313 is good, but
with only one (the ATP–bound structure) or no (the apo structure)
ligand bound it is poor (high b-factor) [11] [12]. It is possible that
the mobility in this region contributes to the diversity of general
anesthetic structures that may inhibit luciferase.
Relationship of photolabeled residues to other ligands
bound at equilibrium
There is an Apo structure of the American luciferase (1BA3.pdb
2.2 A ˚ resolution [17]) with two molecules of the general anesthetic
bromoform bound with half occupancy at each site. Their carbons
are separated by 9.3 A ˚. When the high resolution DSLA–bound
(2D1S.pdb) and the bromoform–bound structures are superim-
posed (Fig. 9), the carbon atom of the inner bromoform, is
centered within 2 A ˚ of the terminal oxygen (O10) of DSLA, and
the bromines overlap C1, C5 and C6 of the benzothiazole ring of
DSLA. Glu-313 is between the two bromoforms, ,5A ˚ from each
carbon. The inner bromoform is positioned close to residues that
we photolabeled, but the outer bromoform occupies a complex
surface pocket, the grotto, separated from the luciferin pocket’s
vestibule by the side chain of Glu-313. The inner bromoform is
well placed to compete with luciferin, and the outer may account
for the allosteric inhibition observed at saturating luciferin
concentrations that overcome competitive inhibition [17]. If the
DSLA structure really represents the activated state, then in
addition to competition with luciferin, modest steric clashes must
be overcome in the binding sites for bromoform (Fig. 9).
In the more recent structures of a truncated American luciferase,
two Apo forms were reported. One (3IER.pdb, 2.05 A ˚)h a d
polyethylene glycol modeled in the luciferin pocket. The second
Apo structure (3IEP.pdb. 2.1 A ˚) lacked this molecule. However, we
observed excess electron density in the vestibule region of 3IEP.pdb
with a shape similar to ethylene glycol. The insets in Fig. S4 show
the result of placing such a molecule by eye. This molecule, like
bromoform, overlaps the terminal region of PTC-124-AMP, a
ligand analogous to DSLA in the Japanese structure. (Fig. S4).
Conclusions
Our findings are consistent with inhibition of luciferase
occurring at an alcohol–binding locus that has the highest affinity
Figure 8. Ligand-induced changes in the vestibule and grotto
region of luciferase. The ‘‘active’’ DSLA bound (left, 2D1S.pdb) and
ATP bound (right, 2D1Q.pdb) structures are compared from the same
viewing points. Upper panels show a cross section through the
vestibule and grotto region beyond the luciferin binding pocket
(compare Fig. 7). The lower panels show the vestibule as viewed from
the luciferin pocket; the left panel shows the O10 of DLSA for
orientation. Water molecules are shown in red in the +ATP structure
and in gold in the DSLA structure (one of the eight water molecules is
partially hidden in panel C and is indicated with a circle). The cross-
section surface capping is semitransparent. Surface coloring is grey for
carbon, red for oxygen and blue for nitrogen. DSLA (gold carbons in A)
is a surrogate for luciferin (Fig. 1B). Similar changes are seen in American
luciferase (3IES.pdb and 3IEP.pdb).
doi:10.1371/journal.pone.0029854.g008
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places the alcohols both in the region of the luciferin pocket that is
intimately associated with luciferin (competitive site) and in the
vestibule in the unoccupied extension of that pocket (allosteric site).
In addition, it is possible that occupancy also occurs in a surface
pocket or grotto adjacent to the vestibule. This is broadly
consistent with the notion that inhibition has both a competitive
and a noncompetitive component [17]. That the sites photolabeled
at 200 ms after adding ATP were the same ones that were
photolabeled with no ATP present supports an allosteric model in
which the affinity but not the location of the sites varies with the
conformation of luciferase.
Supporting Information
Figure S1 Identification of residues photolabeled by 7-
azioctanol (100 mM) in the peptide Tyr-306– Lys-324.
After photolabeling at equilibrium in the absence of ATP,
Japanese firefly luciferase was digested with trypsin and subject
to HPLC-MSMS as described in the Methods section. An 18–
residue tryptic photolabeled peptide bearing a single 128 Da
modification was identified as YDLSNLVEIASGGAPLSK start-
ing at Y306. The site of photoincorporation for 7-azioctanol was
inferred from this MSMS spectrum. In the inset, the predicted
charge/mass ratios of ions with an intact N-terminus (b-ions) or C-
terminus (y-ions) are shown above and below the sequence,
respectively, with the indicated charge. The photolabeled residue
is boxed and the experimentally observed values are colored (b-
ions in red and y-ions in blue) and in bold and their position
indicated on the spectrum. A run of strong y-ions from y14+ to
y4+ with loss of label between y11+ and y10+ identify Glu-313 as
the photolabeled residue. This is confirmed by the b+ ions.
(TIF)
Figure S2 Identification of residues photolabeled by 3-
azibutanol (1 mM) in the peptide Tyr-306– Lys-324. After
treatment as in Fig. S1, an 18–residue tryptic photolabeled peptide
bearing a single 72 Da modification was identified as YDLSNL-
VEIASGGAPLSK starting at Y306. Loss of label was observed
between y11+ and y10+ in a run of strong y-ions, confirming Glu-
313 as the photolabeled residue. This conclusion is also consistent
with the b-ions.
(TIF)
Figure S3 Identification of residues photolabeled by 3-
azioctanol (10 mM) in the peptide Ser-300–Lys324 from
American firefly luciferase. After treatment as in Fig. S1, a
24–residue tryptic photolabeled peptide bearing a single 128 Da
modification was identified as STLIDKYDLSNLHEIASG-
GAPLSK starting at S300. To avoid crowding, some ions are
not labeled in the spectrum. All the observed y-ions were modified,
showing that photolabeling is on or N-terminal to Glu-313
(Japanese numbering). This conclusion is confirmed by a run of b-
ions from b14+ to b3+, with the exception of b10+. The strong
unmodified b++-ions, b16 & 17++, b20++ and b22 & 23++ place
the label on Glu-313 or Ile-314. Aliphatic diazirines do not react
with isoleucine, so we conclude that Glu-313 is photolabeled, as
was found at 100 mM 3-azioctanol (Fig. S1).
(TIF)
Figure S4 Ethylene glycol and bromoform occupy
similar positions in the vestibule. The structure of American
luciferase with PTC-124-AMP bound (3IES.pdb) with the two
bromoform molecules from 1BA3.pdb superimposed, and the
ethylene glycol from 3IEP.pdb (see below). A cross section of 3IES
is shown with surface capping in a surfaced ribbon diagram
(magenta) with the photolabeled residues shown with cyan
carbons. PTC-124-AMP is shown with gold carbons. We observed
excess density at the 3s level in the vestibule region of the Apo
structure (3IEP.pdb). We modeled ethylene glycol by eye in this
density using Coot [23]. The insets show the electron density for
this region. Left inset shows the environment of the ethylene glycol
with the 2Fo electron density at 1s shown in green. The right inset
shows the ethylene glycol in detail with the difference map (Fo2Fc)
in magenta at 3s.
(TIF)
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